Disentangling the Causal Association of Plasma Lipid Traits and Type 2 Diabetes Using Human Genetics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Evidence of heterogeneity in statin-associated type 2 diabetes mellitus risk: A meta-analysis of randomized controlled trials and observational studies.Diabetes research and clinical practice · 2019
   Pooled it
2. Emerging Targets for Cardiovascular Disease Prevention in Diabetes.Trends in molecular medicine · 2020
   Review
3. Human genetic insights into lipoproteins and risk of cardiometabolic disease.Current opinion in lipidology · 2017
   Review

Corrections and comments

• Comment on
  Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.2016

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as